| RS2526710679 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526718012 |
ADAMTSL4
|
Health Risk |
Pathogenic |
Isolated ectopia lentis, Isolated ectopia lentis |
| RS2526720006 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526720289 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526726489 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS2526727709 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS2526729059 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS2526736679 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526751018 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2526755836 |
ASH1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2526756087 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2526757687 |
HUWE1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked syndromic |
| RS2526757763 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2526758787 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2526762309 |
PKP1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex due to plakophilin deficiency, Epidermolysis bullosa simplex due to plakophilin deficiency |
| RS2526767220 |
LEPR
|
Health Risk |
Pathogenic |
— |
| RS2526768089 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526770279 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526771277 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526778229 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526779576 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526780892 |
ADAMTSL4
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2526782628 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS2526786866 |
NEXN
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 20, Dilated cardiomyopathy 1CC |
| RS2526788248 |
ADAMTSL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Ectopia lentis et pupillae, Ectopia lentis 2 |
| RS2526788988 |
NEXN
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 20, Dilated cardiomyopathy 1CC |
| RS2526801099 |
ADAMTSL4
|
Health Risk |
Likely pathogenic |
— |
| RS2526809677 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2526809987 |
KCNH1
|
Health Risk |
Likely pathogenic |
KCNH1-related disorder, KCNH1-related disorder |
| RS2526809998 |
PBX1
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2526810325 |
PBX1
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2526810620 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2526811415 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS2526811497 |
DDR2
|
Health Risk |
Likely pathogenic |
— |
| RS2526829751 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2526835356 |
DDR2
|
Health Risk |
Pathogenic |
— |
| RS2526835712 |
KCNH1
|
Health Risk |
Likely pathogenic |
KCNH1-related disorder, KCNH1-related disorder |
| RS2526841964 |
DSTYK
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract 1, Congenital anomalies of kidney and urinary tract 1 |
| RS2526845931 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2526855331 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2526855476 |
PBX1
|
Health Risk |
Likely pathogenic |
Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears |
| RS2526867772 |
ALDH18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
de Barsy syndrome, Autosomal dominant spastic paraplegia type 9 |
| RS2526881783 |
PBX1
|
Health Risk |
Pathogenic |
— |
| RS2526888534 |
MUC1
|
Health Risk |
Likely pathogenic |
Tubulointerstitial kidney disease, autosomal dominant |
| RS2526890961 |
EDARADD
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type |
| RS2526897392 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS2526899878 |
ALDH18A1
|
Health Risk |
Likely pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS2526900150 |
ALDH18A1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal dominant 3 |
| RS2526906935 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2526907455 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2526908392 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2526908416 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
LYST-related disorder, Chédiak-Higashi syndrome |
| RS2526911861 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2526914541 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2526922942 |
CD55
|
Health Risk |
Likely pathogenic |
CD55-related disorder, CD55-related disorder |
| RS2526924702 |
CD55
|
Health Risk |
Pathogenic |
— |
| RS2526924725 |
CD55
|
Health Risk |
Pathogenic |
— |
| RS2526927321 |
EDARADD
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type |
| RS2526932418 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2526937956 |
TBCE
|
Health Risk |
Likely pathogenic |
— |
| RS2526941929 |
TNNT2
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2526947236 |
CD55
|
Health Risk |
Likely pathogenic |
— |
| RS2526953654 |
TNNT2
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy 2 |
| RS2526964523 |
CD55
|
Health Risk |
Likely pathogenic |
— |
| RS2526967162 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2526969474 |
SYT2
|
Health Risk |
Pathogenic |
— |
| RS2526974512 |
SYT2
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 7, Congenital myasthenic syndrome 7 |
| RS2526989632 |
SYT2
|
Health Risk |
Likely pathogenic |
Myasthenic syndrome, congenital |
| RS2526991185 |
PIGC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 16, Global developmental delay |
| RS2526991704 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2526997211 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2526997302 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527008372 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527008662 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527012076 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527012164 |
TBCE
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527012174 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527012751 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527013115 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527013203 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527014983 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527016118 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 2 |
| RS2527016426 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527016878 |
GNPAT
|
Health Risk |
Likely pathogenic |
— |
| RS2527016939 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527017267 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527017466 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527021944 |
GNPAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527022021 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527022406 |
GNPAT
|
Health Risk |
Likely pathogenic |
— |
| RS2527022409 |
GNPAT
|
Health Risk |
Likely pathogenic |
— |
| RS2527024491 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527024495 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527024540 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527024799 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527024851 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527024893 |
TNNT2
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS2527024941 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527024984 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527028214 |
TBCE
|
Health Risk |
Pathogenic |
— |